Disease burden of herpes zoster in Korea

Choi, Won Suk; Noh, Ji Yun; Huh, Joong Yeon; Jo, Yu Mi; Jacob, Louis; Song, Joon Young; Cheong, Hee Jin

doi:10.1016/j.jcv.2010.01.003

Cited by 40 publications

(46 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Korea, Choi et al found that HZ-related costs increased each year by 14-20%, with medical costs being the main component (51-54%) of the total costs. 34 Particularly high costs are incurred by HZ patients suffering from immuno-deficiencies, severe malignancies and comorbidities. 35,44,47,48,52,54,58 Moreover, costs are correlated with the duration of hospitalization and the severity of the disease.…”

Section: Hospitalization Costsmentioning

confidence: 99%

Evaluation of the economic burden of Herpes Zoster (HZ) infection

Panatto

Bragazzi

Rizzitelli

et al. 2015

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

The main objective of this systematic review was to evaluate the economic burden of Herpes Zoster (HZ) infection. The review was conducted in accordance with the standards of the "Preferred Reporting Items for Systematic Reviews and Meta-Analyses" guidelines. The following databases were accessed: ISI/Web of Knowledge (WoS), MEDLINE/PubMed, Scopus, ProQuest, the Cochrane Library and EconLit. Specific literature on health economics was also manually inspected. Thirty-three studies were included. The quality of the studies assessed in accordance with the Consolidated Health Economic Evaluation Reporting Standards checklist was good. All studies evaluated direct costs, apart from one which dealt only with indirect costs. Indirect costs were evaluated by 12 studies. The economic burden of HZ has increased over time. HZ management and drug prescriptions generate the highest direct costs. While increasing age, co-morbidities and drug treatment were found to predict higher direct costs, being employed was correlated with higher indirect costs, and thus with the onset age of the disease. Despite some differences among the selected studies, particularly with regard to indirect costs, all concur that HZ is a widespread disease which has a heavy social and economic burden.

show abstract

Section: Hospitalization Costsmentioning

confidence: 99%

Evaluation of the economic burden of Herpes Zoster (HZ) infection

Panatto

Bragazzi

Rizzitelli

et al. 2015

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

show abstract

“…31 Also a progressive increase in rates was found in Korea between 2003 and 2007, where varicella vaccine was introduced to the childhood immunization program in 2005. 39 In Australia, with varicella vaccination publically funded since 2005, different studies found an upward trend for HZ-related hospitalizations and, with those aged 80 years and over experiencing the most substancial increase when limited to primary diagnosis. 30,36,40 The available evidence does not allow to directly attribute the increasing trends in HZ observed to the immunization against VZV.…”

Section: Temporal Trendsmentioning

confidence: 99%

Temporal trends in herpes zoster-related hospitalizations in Madrid (Spain), 2003–2013

Esteban-Vasallo

Domínguez‐Berjón

Gil-Prieto

et al. 2015

Journal of Infection

View full text Add to dashboard Cite

“…[11][12][13][14] In 2040, the proportion of people aged 65 y is expected to reach 32.3%, which is about 3 times higher than the current proportion in South Korea and this trend has been observed in other countries too. [15][16][17] Accordingly, HZ vaccination may play an important role in promoting healthy aging.…”

Section: Introductionmentioning

confidence: 99%

Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea

Yang

Cheong

Song

et al. 2015

Human Vaccines & Immunotherapeutics

Self Cite

View full text Add to dashboard Cite

A cross-sectional study was performed to assess current public awareness of herpes zoster (HZ) and its vaccine, determine the factors that influence people's intention regarding HZ vaccination, and investigate the barriers for vaccination by changing decisions with sequential questions regarding knowledge, cost, and physician's recommendation in the Department of Infectious Diseases, Korea University Guro Hospital, in South Korea, between August 23 and September 15 of 2013. Among 603 subjects who completed the survey, 85.7% and 43.6% subjects were aware of HZ and HZ vaccination, respectively. Women, younger age group, those with higher income or higher education levels were more likely to be aware of HZ. Overall, 85.8% of subjects aware of HZ were willing to be vaccinated or vaccinate their parents. The main obstacles for the increased acceptance toward vaccination were the high cost and low perceived risk, which decreased acceptance to 60.2%. However, physician's recommendation reversed 69.5% of the refusal to accept HZ vaccine. These results indicate that expanding public education and physician's recommendations are important factors aimed at increasing HZ vaccine coverage rate.

show abstract

Disease burden of herpes zoster in Korea

Cited by 40 publications

References 21 publications

Evaluation of the economic burden of Herpes Zoster (HZ) infection

Evaluation of the economic burden of Herpes Zoster (HZ) infection

Temporal trends in herpes zoster-related hospitalizations in Madrid (Spain), 2003–2013

Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea

Contact Info

Product

Resources

About